Torsten Haferlach

Torsten Haferlach

UNVERIFIED PROFILE

Are you Torsten Haferlach?   Register this Author

Register author
Torsten Haferlach

Torsten Haferlach

Publications by authors named "Torsten Haferlach"

Are you Torsten Haferlach?   Register this Author

100Publications

3188Reads

7Profile Views

Impact of assay procedures on detection of MR status in chronic myeloid leukemia: Optimization of cDNA synthesis.

Int J Lab Hematol 2019 10 12;41(5):e109-e112. Epub 2019 Mar 12.

MLL Munich Leukemia Laboratory, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijlh.13004DOI Listing
October 2019

Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.

Genes Chromosomes Cancer 2019 10 1;58(10):698-704. Epub 2019 May 1.

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22761DOI Listing
October 2019

Evidence of clonality in cases of hypereosinophilia of undetermined significance.

Leuk Lymphoma 2019 Aug 18;60(8):2071-2074. Epub 2019 Jan 18.

a MLL Munich Leukemia Laboratory , Munich , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1564825DOI Listing
August 2019

Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based study.

Eur J Haematol 2019 Jul 15. Epub 2019 Jul 15.

Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13293DOI Listing
July 2019

More than a fusion gene: the - AML.

Blood 2019 Mar;133(10):1006-1007

MLL Munich Leukemia Laboratory.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2019-01-896076DOI Listing
March 2019

Impact of 9q deletions on the classification of patients with acute myeloid leukemia.

J Cancer Res Clin Oncol 2019 Mar 29. Epub 2019 Mar 29.

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-02908-0DOI Listing
March 2019

Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.

Haematologica 2019 Feb 6;104(2):277-287. Epub 2018 Sep 6.

Department of Hematology, Oncology and Immunology, Philipps-University Marburg, and University Hospital Gießen and Marburg, Marburg, Germany

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.194258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355503PMC
February 2019

The Molecular Pathology of Myelodysplastic Syndrome.

Pathobiology 2019 23;86(1):24-29. Epub 2018 May 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000488712DOI Listing
January 2019

Molecular patterns in cytopenia patients with or without evidence of myeloid neoplasm-a comparison of 756 cases.

Leukemia 2018 10 30;32(10):2295-2298. Epub 2018 Mar 30.

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0119-8DOI Listing
October 2018

Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing.

Leukemia 2018 05 26;32(5):1229-1238. Epub 2018 Feb 26.

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-017-0002-zDOI Listing
May 2018

The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability.

Biochim Biophys Acta Mol Cell Res 2018 Jan 20;1865(1):105-116. Epub 2017 Sep 20.

Department of Medical and Molecular Genetics, King's College London, Faculty of Life Sciences and Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2017.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701546PMC
January 2018

Disease-modifying activity of ruxolitinib in a patient with JAK2-negative CMML-2.

Leuk Lymphoma 2017 05 23;58(5):1271-1272. Epub 2016 Sep 23.

a Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl-Gustav-Carus, Technische Universität , Dresden , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1225209DOI Listing
May 2017

BCR-ABL1-positive and JAK2 V617F-positive clones in 23 patients with both aberrations reveal biologic and clinical importance.

Br J Haematol 2017 01 5;176(1):135-139. Epub 2016 Feb 5.

Munich Leukaemia Laboratory GmbH, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13932DOI Listing
January 2017

Cord-Blood Transplantation in Patients with Minimal Residual Disease.

N Engl J Med 2016 12;375(22):2204

Aarhus University Hospital, Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1612872DOI Listing
December 2016

The 5q deletion size in myeloid malignancies is correlated to additional chromosomal aberrations and to TP53 mutations.

Genes Chromosomes Cancer 2016 10 4;55(10):777-85. Epub 2016 Jul 4.

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22377DOI Listing
October 2016

MYC rearranged B-cell neoplasms: Impact of genetics on classification.

Cancer Genet 2016 Oct 14;209(10):431-439. Epub 2016 Sep 14.

MLL Munich Leukemia Laboratory, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2016.08.007DOI Listing
October 2016

Genetic characterization of T-PLL reveals two major biologic subgroups and JAK3 mutations as prognostic marker.

Genes Chromosomes Cancer 2016 Jan 23;55(1):82-94. Epub 2015 Oct 23.

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, 81377, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22313DOI Listing
January 2016

Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.

Blood 2016 Jan 27;127(4):436-48. Epub 2015 Oct 27.

3rd Department of Medicine, Technical University Munich, Munich, Germany; Department of Haematology, University of Cambridge, Cambridge, United Kingdom;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-05-646935DOI Listing
January 2016

Why germline variations in ALL can matter.

Lancet Oncol 2015 Dec 28;16(16):1577-8. Epub 2015 Oct 28.

MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377 München, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00440-4DOI Listing
December 2015

The kinetics of relapse in DEK-NUP214-positive acute myeloid leukemia patients.

Eur J Haematol 2015 Nov 13;95(5):436-41. Epub 2015 Mar 13.

MLL Munich Leukemia Laboratory, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12511DOI Listing
November 2015

Leukemia diagnosis: today and tomorrow.

Eur J Haematol 2015 Oct 26;95(4):365-73. Epub 2015 Jul 26.

Hematology and Clinical Pathology, Catholic University of Sacred Heart, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12603DOI Listing
October 2015

Mutational profiling in patients with MDS: ready for every-day use in the clinic?

Best Pract Res Clin Haematol 2015 Mar 12;28(1):32-42. Epub 2014 Nov 12.

MLL Munich Leukemia Laboratory, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.11.005DOI Listing
March 2015

Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia.

Br J Haematol 2015 Jan 19;168(1):153-6. Epub 2014 Aug 19.

MLL Munich Leukaemia Laboratory, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13077DOI Listing
January 2015

Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia.

Haematologica 2015 Jan 26;100(1):e4-6. Epub 2014 Sep 26.

Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.115055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281320PMC
January 2015

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome.

Nat Commun 2015 Jan 14;6:6042. Epub 2015 Jan 14.

1] Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, 12-01, Singapore 117599, Singapore [2] Cedars-Sinai Medical Center, Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, California 90048, USA [3] National University Cancer Institute, National University Hospital Singapore, Singapore 119228, Singapore.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncomms7042
Publisher Site
http://dx.doi.org/10.1038/ncomms7042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349895PMC
January 2015

Quantification of rare NPM1 mutation subtypes by digital PCR.

Br J Haematol 2014 Dec 18;167(5):710-4. Epub 2014 Jul 18.

MLL Munich Leukaemia Laboratory, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13038DOI Listing
December 2014

Should clinical hematologists put their microscopes on eBay?

Haematologica 2014 Oct;99(10):1533-4

MLL Munich Leukemia Laboratory, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.114710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181246PMC
October 2014